bpc 157 human trials 2021 If BPC-157 worked as well as the internet says it does… …we'd probably have high quality by now. Instead we have... Lots of rat studies. Lots of podcasts. Lots of If BPC-157 worked as well

In cognitive studies on elderly mice (28 months old), GHK-Cu administered at 10 mg/kg five times per week for three weeks produced significantly faster maze navigation, suggesting partial reversal of age-related cognitive decline

BAFF: a local and systemic target in autoimmune diseases

Small wins lock together

SURMOUNT-OSA: Tirzepatide and obstructive sleep apnea The SURMOUNT-OSA trial (Malhotra et al., NEJM 2024, NEJMoa2404881, PMID 38912654) evaluated tirzepatide in adults with moderate to severe obstructive sleep apnea and obesity, in two parallel populations: subjects not receiving continuous positive airway pressure (CPAP) and subjects receiving CPAP at baseline

BPC-157 is a short lab-made peptide a chain of 15 amino acids modeled after a small piece of a protein found naturally in the lining of the stomach